CROSSJECT (FRA:74C) Other Current Payables: €0.00 Mil (As of Dec. 2025)


FRA:74C CROSSJECT FRA:74C
40 GF Score
Price €1.52
GF Value €1.07
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is CROSSJECT Other Current Payables?

CROSSJECT FRA:74C +0.26% 40 Other Current Payables is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:74C with a GF Score™ of 40/100 and a GF Value™ of €1.07 (Significantly Overvalued). The stock has 4 warning signs investors should review.

CROSSJECT's Other Current Payables for the quarter that ended in Dec. 2025 was €0.00 Mil.

CROSSJECT Other Current Payables Related Terms

CROSSJECT Other Current Payables Historical Data

* Premium members only.

The historical data trend for CROSSJECT's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CROSSJECT Other Current Payables Chart

CROSSJECT Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CROSSJECT Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:74C
40GF Score
CROSSJECT FRA:74C
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CROSSJECT Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €0.00 Mil mean?
CROSSJECT (FRA:74C) has a Other Current Payables of €0.00 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on CROSSJECT and its competitors.
Is CROSSJECT's Other Current Payables too high?
CROSSJECT's current Other Current Payables is €0.00 Mil. Overall, CROSSJECT has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CROSSJECT's Other Current Payables compare to ISRG and BDX?
CROSSJECT's Other Current Payables of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on CROSSJECT and its competitors. CROSSJECT's current Other Current Payables is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CROSSJECT stock overvalued right now?
Based on GuruFocus' analysis, CROSSJECT (FRA:74C) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.07, compared to a current price of €1.52 — trading 41.9% above its estimated fair value. The current Other Current Payables is €0.00 Mil. CROSSJECT's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For CROSSJECT (FRA:74C), the current Other Current Payables is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CROSSJECT (FRA:74C) Overvalued in 2026?

Based on GuruFocus' analysis, CROSSJECT stock appears to be overvalued. The current stock price of €1.52 is trading 41.9% above its estimated GF Value™ of €1.07. GuruFocus considers CROSSJECT to be Significantly Overvalued.

Key valuation signals for FRA:74C:

  • Other Current Payables: €0.00 Mil
  • GF Value™: €1.07 vs. price of €1.52 (41.9% above fair value)
  • GF Score™: 40/100 with 4 warning signs

No single metric tells the full story. See the FRA:74C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CROSSJECT Business Description

Other Exchanges ALCJ:France74C:Germany
Address 60L avenue du 14 Juillet, Chenôve, FRA, 21300
CROSSJECT manufactures and markets needle-free drug self-injection system.
40GF Score

Get the complete analysis for FRA:74C

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.52
Price
€1.07
GF Value